Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2012, Article ID 879368, 10 pages
http://dx.doi.org/10.1155/2012/879368
Review Article

Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies

Research Institute for Clinical Oncology, Saitama Cancer Center, Komuro 818, Ina-machi, Saitama 362-0806, Japan

Received 25 May 2011; Accepted 29 June 2011

Academic Editor: Kevin D. Bunting

Copyright © 2012 Junko Okabe-Kado et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Steeg, G. Bevilacqua, L. Kopper et al., “Evidence for a novel gene associated with low tumor metastatic potential,” Journal of the National Cancer Institute, vol. 80, no. 3, pp. 200–204, 1988. View at Google Scholar · View at Scopus
  2. M. L. Lacombe, L. Milon, A. Munier, J. G. Mehus, and D. O. Lambeth, “The human Nm23/Nucleoside diphosphate kinases,” Journal of Bioenergetics and Biomembranes, vol. 32, no. 3, pp. 247–258, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Lascu and P. Gonin, “The catalytic mechanism of nucleoside diphosphate kinases,” Journal of Bioenergetics and Biomembranes, vol. 32, no. 3, pp. 237–246, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. MacDonald, A. De la Rosa, and P. S. Steeg, “The potential roles of nm23 in cancer metastasis and cellular differentiation,” European Journal of Cancer Part A: General Topics, vol. 31, no. 7-8, pp. 1096–1100, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bilitou, J. Watson, A. Gartner, and S. I. Ohnuma, “The NM23 family in development,” Molecular and Cellular Biochemistry, vol. 329, no. 1-2, pp. 17–33, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. E. Horak, H. L. Jong, A. G. Elkahloun et al., “Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2,” Cancer Research, vol. 67, no. 15, pp. 7238–7246, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. L. Lacombe, X. Sastre-Garau, I. Lascu et al., “Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours,” European Journal of Cancer, vol. 27, no. 10, pp. 1302–1307, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Hailat, D. R. Keim, R. F. Melhem et al., “High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification,” Journal of Clinical Investigation, vol. 88, no. 1, pp. 341–345, 1991. View at Google Scholar · View at Scopus
  9. A. Leone, R. C. Seeger, C. M. Hong et al., “Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas,” Oncogene, vol. 8, no. 4, pp. 855–865, 1993. View at Google Scholar · View at Scopus
  10. A. Yokoyama, J. Okabe-Kado, N. Wakimoto et al., “Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies,” Blood, vol. 91, no. 6, pp. 1845–1851, 1998. View at Google Scholar · View at Scopus
  11. N. Niitsu, J. Okabe-Kado, M. Okamoto et al., “Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma,” Blood, vol. 97, no. 5, pp. 1202–1210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Okabe-Kado, M. Hayashi, Y. Honma, and M. Hozumi, “Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells,” Cancer Research, vol. 45, no. 10, pp. 4848–4852, 1985. View at Google Scholar · View at Scopus
  13. J. Okabe-Kado, T. Kasukabe, Y. Honma, M. Hayashi, and M. Hozumi, “Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells,” Journal of Biological Chemistry, vol. 263, no. 22, pp. 10994–10999, 1988. View at Google Scholar · View at Scopus
  14. J. Okabe-Kado, T. Kasukabe, Y. Honma, M. Hayashi, and W. J. Henzel, “Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase,” Biochemical and Biophysical Research Communications, vol. 182, no. 3, pp. 987–994, 1992. View at Google Scholar
  15. N. Wakimoto, A. Yokoyama, Y. Mukai et al., “Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia,” International Journal of Hematology, vol. 67, no. 3, pp. 313–318, 1998. View at Google Scholar · View at Scopus
  16. D. N. T. Aryee, I. Simonitsch, I. Mosberger et al., “Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness,” British Journal of Cancer, vol. 74, no. 11, pp. 1693–1698, 1996. View at Google Scholar · View at Scopus
  17. N. Niitsu, H. Nakamine, M. Okamoto et al., “Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma,” British Journal of Haematology, vol. 123, no. 4, pp. 621–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Niitsu, H. Nakamine, M. Okamoto et al., “Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma,” Clinical Cancer Research, vol. 10, no. 7, pp. 2482–2490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Niitsu, H. Nakamine, M. Okamoto, J. I. Tamaru, and M. Hirano, “A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma,” Annals of Oncology, vol. 19, no. 11, pp. 1941–1946, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. Yokoyama, J. Okabe-Kado, A. Sakashita et al., “Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia,” Blood, vol. 88, no. 9, pp. 3555–3561, 1996. View at Google Scholar · View at Scopus
  21. N. Wakimoto, A. Yokoyama, J. Okabe-Kado, N. Nagata, K. Motoyoshi, and Y. Honma, “Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia,” British Journal of Cancer, vol. 77, no. 12, pp. 2298–2303, 1998. View at Google Scholar · View at Scopus
  22. R. Willems, D. R. Van Bockstaele, F. Lardon et al., “Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation,” Journal of Biological Chemistry, vol. 273, no. 22, pp. 13663–13668, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Yamashiro, T. Urano, H. Shiku, and K. Furukawa, “Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines,” Oncogene, vol. 9, no. 9, pp. 2461–2468, 1994. View at Google Scholar · View at Scopus
  24. M. A. Caligo, G. Cipollini, M. Petrinit, P. Valentini, and G. Bevilacqua, “Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3,” Leukemia Research, vol. 20, no. 2, pp. 161–167, 1996. View at Publisher · View at Google Scholar
  25. N. Niitsu, J. Okabe-Kado, T. Kasukabe, Y. Yamamoto-Yamaguchi, M. Umeda, and Y. Honma, “Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma,” Blood, vol. 94, no. 10, pp. 3541–3550, 1999. View at Google Scholar · View at Scopus
  26. T. Urano, K. Furukawa, and H. Shiku, “Expression of nm23/NDP kinase proteins on the cell surface,” Oncogene, vol. 8, no. 5, pp. 1371–1376, 1993. View at Google Scholar · View at Scopus
  27. J. Anzinger, N. A. Malmquist, J. Gould, and I. L. O. Buxton, “Secretion of a nucleoside diphosphate kinase (Nm23-H2) by cells from human breast, colon, pancreas and lung tumors,” Proceedings of the Western Pharmacology Society, vol. 44, pp. 61–63, 2001. View at Google Scholar · View at Scopus
  28. S. M. Rumjahn, M. A. Javed, N. Wong, W. E. Law, and I. L. O. Buxton, “Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase,” British Journal of Cancer, vol. 97, no. 10, pp. 1372–1380, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M. Keller, A. Rüegg, S. Werner, and H. D. Beer, “Active caspase-1 is a regulator of unconventional protein secretion,” Cell, vol. 132, no. 5, pp. 818–831, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. Chairoungdua, D. L. Smith, P. Pochard, M. Hull, and M. J. Caplan, “Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling,” Journal of Cell Biology, vol. 190, no. 6, pp. 1079–1091, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Okabe-Kado, “Serum nm23-H1 protein as a prognostic factor in hematological malignancies,” Leukemia and Lymphoma, vol. 43, no. 4, pp. 859–867, 2002. View at Publisher · View at Google Scholar · View at PubMed
  32. N. Niitsu, J. Okabe-Kado, M. Nakayama et al., “Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia,” Blood, vol. 96, no. 3, pp. 1080–1086, 2000. View at Google Scholar
  33. J. Okabe-Kado, T. Kasukabe, Y. Honma, H. Kobayashi, N. Maseki, and Y. Kaneko, “Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells,” Cancer Science, vol. 100, no. 10, pp. 1885–1894, 2009. View at Publisher · View at Google Scholar · View at PubMed
  34. J. Okabe-Kado, T. Kasukabe, Y. Honma, H. Kobayashi, N. Maseki, and Y. Kaneko, “Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production,” International Journal of Hematology, vol. 90, no. 2, pp. 143–152, 2009. View at Publisher · View at Google Scholar · View at PubMed
  35. J. Okabe-Kado, T. Kasukabe, Y. Honma, R. Hanada, A. Nakagawara, and Y. Kaneko, “Clinical significance of serum NM23-H1 protein in neuroblastoma,” Cancer Science, vol. 96, no. 10, pp. 653–660, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. J. Okabe-Kado, T. Kasukabe, and Y. Honma, “Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages,” Leukemia Research, vol. 26, no. 6, pp. 569–576, 2002. View at Publisher · View at Google Scholar
  37. Z. Wen, Z. Zhong, and J. E. Darnell Jr., “Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation,” Cell, vol. 82, no. 2, pp. 241–250, 1995. View at Google Scholar
  38. A. C. Bharti, N. Donato, and B. B. Aggarwal, “Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells,” Journal of Immunology, vol. 171, no. 7, pp. 3863–3871, 2003. View at Google Scholar
  39. J. C. Lee, S. Kumar, D. E. Griswold, D. C. Underwood, B. J. Votta, and J. L. Adams, “Inhibition of p38 MAP kinase as a therapeutic strategy,” Immunopharmacology, vol. 47, no. 2-3, pp. 185–201, 2000. View at Publisher · View at Google Scholar
  40. A. J. Lilly, F. L. Khanim, R. E. Hayden, Q. T. Luong, M. T. Drayson, and C. M. Bunce, “Nm23-H1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone,” Cancer Research, vol. 71, no. 3, pp. 1177–1186, 2011. View at Publisher · View at Google Scholar · View at PubMed
  41. A. Mantovani, “B cells and macrophages in cancer: Yin and yang,” Nature Medicine, vol. 17, no. 3, pp. 285–286, 2011. View at Publisher · View at Google Scholar · View at PubMed
  42. N. Díaz-Valdés, M. Basagoiti, J. Dotor et al., “Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFβ1 in melanoma enhances tumor infiltration and immunosuppression,” Cancer Research, vol. 71, no. 3, pp. 812–821, 2011. View at Publisher · View at Google Scholar · View at PubMed
  43. S. K. Biswas and A. Mantovani, “Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm,” Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. I. L. O. Buxton, N. Yokdang, and R. M. Matz, “Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis,” Cancer Letters, vol. 291, no. 2, pp. 131–141, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. C. Steidl, T. Lee, S. P. Shah et al., “Tumor-associated macrophages and survival in classic Hodgkin's lymphoma,” New England Journal of Medicine, vol. 362, no. 10, pp. 875–885, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. R. Willems, H. Slegers, I. Rodrigus et al., “Extracellular nucleoside diphosphate kinase NM23/NDPK modulates normal hematopoietic differentiation,” Experimental Hematology, vol. 30, no. 7, pp. 640–648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Okabe-Kado, T. Kasukabe, H. Baba, T. Urano, H. Shiku, and Y. Honma, “Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1267, no. 2-3, pp. 101–106, 1995. View at Publisher · View at Google Scholar
  48. L. Chin, J. N. Andersen, and P. A. Futreal, “Cancer genomics: from discovery science to personalized medicine,” Nature Medicine, vol. 17, no. 3, pp. 297–303, 2011. View at Publisher · View at Google Scholar · View at PubMed
  49. T. E. Ichim, Z. Zhong, S. Kaushal et al., “Exosomes as a tumor immune escape mechanism: possible therapeutic implications,” Journal of Translational Medicine, vol. 6, no. 37, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. S. Mahanta, S. P. Fessles, J. Park, and C. Bamdad, “A minimal fragments of MUC1 mediates growth of cancer cells,” PLoS ONE, vol. 3, no. 4, Article ID e2054, 2008. View at Publisher · View at Google Scholar · View at PubMed
  51. S. T. Hikita, K. S. Kosik, D. O. Clegg, and C. Bamdad, “MUC1* mediates the growth of human pluripotent stem cells,” PLoS ONE, vol. 3, no. 10, Article ID e3312, 2008. View at Publisher · View at Google Scholar · View at PubMed
  52. L. Apetoh, F. Ghiringhelli, A. Tesniere et al., “Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy,” Nature Medicine, vol. 13, no. 9, pp. 1050–1059, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. S. Y. Seong and P. Matzinger, “Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses,” Nature Reviews Immunology, vol. 4, no. 6, pp. 469–478, 2004. View at Google Scholar · View at Scopus
  54. J. C. Lee, S. Kumar, D. E. Griswold, D. C. Underwood, B. J. Votta, and J. L. Adams, “Inhibition of p38 MAP kinase as a therapeutic strategy,” Immunopharmacology, vol. 47, no. 2-3, pp. 185–201, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. A. C. Bharti, N. Donato, and B. B. Aggarwal, “Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells,” Journal of Immunology, vol. 171, no. 7, pp. 3863–3871, 2003. View at Google Scholar · View at Scopus
  56. B. D. Page, D. P. Ball, and P. T. Gunning, “Signal transducer and activator of transcription 3 inhibitors: a patent review,” Expert Opinion on Therapeutic Patents, vol. 21, no. 1, pp. 65–83, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. Karin, “Inflammation and cancer: the long reach of Ras,” Nature Medicine, vol. 11, no. 1, pp. 20–21, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. A. M. Gilles, E. Presecan, A. Vonica, and I. Lascu, “Nucleoside diphosphate kinase from human erythrocytes: structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme,” Journal of Biological Chemistry, vol. 266, no. 14, pp. 8784–8789, 1991. View at Google Scholar · View at Scopus
  59. J. A. Stahl, A. Leone, A. M. Rosengard, L. Porter, C. R. King, and P. S. Steeg, “Identification of a second human nm23 gene, nm23-H2,” Cancer Research, vol. 51, no. 1, pp. 445–449, 1991. View at Google Scholar · View at Scopus
  60. E. H. Postel, S. J. Berberich, S. J. Flint, and C. A. Ferrone, “Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis,” Science, vol. 261, no. 5120, pp. 478–480, 1993. View at Google Scholar · View at Scopus
  61. P. D. Wagner and N. D. Vu, “Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase,” Journal of Biological Chemistry, vol. 270, no. 37, pp. 21758–21764, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. Q. Lu, H. Park, L. A. Egger, and M. Inouye, “Nucleoside-diphosphate kinase-mediated signal transduction via histidyl-aspartyl phosphorelay systems in Escherichia coli,” Journal of Biological Chemistry, vol. 271, no. 51, pp. 32886–32893, 1996. View at Google Scholar · View at Scopus
  63. G. Paravicini, M. Steinmayr, E. André, and M. Becker-André, “The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily,” Biochemical and Biophysical Research Communications, vol. 227, no. 1, pp. 82–87, 1996. View at Publisher · View at Google Scholar · View at PubMed
  64. S. M. Leung and L. E. Hightower, “A 16-kDa protein functions as a new regulatory protein for Hsc70 molecular chaperone and is identified as a member of the Nm23/nucleoside diphosphate kinase family,” Journal of Biological Chemistry, vol. 272, no. 5, pp. 2607–2614, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Nosaka, M. Kawahara, M. Masuda, Y. Satomi, and H. Nishino, “Association of nucleoside diphosphate kinase nm23-H2 with human telomeres,” Biochemical and Biophysical Research Communications, vol. 243, no. 2, pp. 342–348, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. C. Subramanian, M. A. Cotter II, and E. S. Robertson, “Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis,” Nature Medicine, vol. 7, no. 3, pp. 350–355, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. A. D'Angelo, L. Garzia, A. André et al., “Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis,” Cancer Cell, vol. 5, no. 2, pp. 137–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Zhu, Y. H. Tseng, J. D. Kantor et al., “Interaction of the Ras-related protein associated with diabetes Rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 26, pp. 14911–14918, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. H. Tseng, D. Vicent, J. Zhu et al., “Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and Nm23,” Cancer Research, vol. 61, no. 5, pp. 2071–2079, 2001. View at Google Scholar · View at Scopus
  70. S. Zhu, H. Wurdak, J. Wang et al., “A small molecule primes embryonic stem cells for differentiation,” Cell Stem Cell, vol. 4, no. 5, pp. 416–426, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. L. Ji, M. Arcinas, and L. M. Boxer, “The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma,” Journal of Biological Chemistry, vol. 270, no. 22, pp. 13392–13398, 1995. View at Google Scholar · View at Scopus
  72. P. S. Steeg, K. H. Cohn, and A. Leone, “Tumor metastasis and nm23: current concepts,” Cancer Cells, vol. 3, no. 7, pp. 257–262, 1991. View at Google Scholar · View at Scopus
  73. A. Yamaguchi, T. Urano, S. Fushida et al., “Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis,” British Journal of Cancer, vol. 68, no. 5, pp. 1020–1024, 1993. View at Google Scholar · View at Scopus
  74. H. Miyazaki, M. Fukuda, Y. Ishijima et al., “Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture,” Clinical Cancer Research, vol. 5, no. 12, pp. 4301–4307, 1999. View at Google Scholar · View at Scopus
  75. S. Tschiedel, C. Gentilini, T. Lange et al., “Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia,” Leukemia, vol. 22, no. 8, pp. 1542–1550, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. N. I. Ismail, G. Kaur, H. Hashim, and M. S. Hassan, “Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression,” Cancer Cell International, vol. 8, article 6, 2008. View at Publisher · View at Google Scholar · View at PubMed
  77. C. G. Hsu, L. Y. Lin, J. L. Ko et al., “High expression of human nonmetastatic clone 23 type 1 in cancer of uterine cervix and its association with poor cell differentiation and worse overall survival,” Journal of Surgical Oncology, vol. 98, no. 6, pp. 448–456, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. S. M. Rumjahn, K. A. Baldwin, and I. L. O. Buxton, “P2y receptor-mediated angiogenesis via vascular endothelial growth factor receptor 2 signaling,” Proceedings of the Western Pharmacology Society, vol. 50, pp. 58–60, 2007. View at Google Scholar · View at Scopus
  79. I. L. O. Buxton, S. M. Rumjahn, N. Yokdang, K. A. Baldwin, and J. Thai, “Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis,” British Journal of Cancer, vol. 100, no. 9, pp. 1465–1470, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. I. L. O. Buxton, “Inhibition of Nm23H2 gene product (NDPK-B) by angiostatin, polyphenols and nucleoside analogs,” Proceedings of the Western Pharmacology Society, vol. 51, pp. 30–34, 2008. View at Google Scholar · View at Scopus
  81. Y. Hagiwara, T. Kasukabe, Y. Kaneko, N. Niitsu, and J. Okabe-Kado, “Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells,” International Journal of Hematology, vol. 92, no. 1, pp. 136–143, 2010. View at Publisher · View at Google Scholar · View at PubMed